Taken as a whole, these results support the concept that by regulating basal and chronic low-level activation of NF-κB, the abundance of UBE2L3 might play a major regulatory role in abnormal B cell differentiation and proliferation in autoimmune diseases. This evidence concerns the gene NFKB1 and autoimmune disease.